Authors:
Timothy E. Ritter, MD – Texas Digestive Disease Consultants, PLLC, Southlake, TX
Christopher Fourment, MD – Texas Digestive Disease Consultants, PLLC, Southlake, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX
Tracy C. Okoro, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX
Thomas C. Hardin, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX
Real World Evaluation of Prolonged Clinical Response with Vedolizumab in Crohn’s Disease and Ulcerative Colitis patients Treated in a Private Practice Setting
